Topic: Affective Disorders (Unipolar)

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	FC-01 - Free Communications
Time:	08.00-09.30
Room:	Room 351
Topic:	Affective Disorders (Unipolar)
Session title:	Affective Disorders (Unipolar) I
	Michael Bauer, Germany	Chair
	Zoltan Rihmer, Hungary	Co-Chair

001	The effect of cortisol suppression on emotionasl stress responses in depressives and controls
	Petra Netter, Germany	Speaker
002	Cortical inhibitory deficits in major depressive disorder
	Andrea Levinson, Canada	Speaker
004	Increased self-focus in major depressive disorder is related to neural abnormalities in subcortical-cortical midline structures
	Jutta Ernst, Switzerland	Speaker
005	Altered negative bold responses in the default-mode network during emotion processing in depressed subjects
	Simone Grimm, Switzerland	Speaker

No.	P-02 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Affective Disorders (Unipolar)
Session title:	Affective Disorders (Unipolar) I
	Rajesh Nagpal, India	Chair

001	Executive control of emotion in depression
	Melissa Green, Australia	Presenter
002	Selective response of dopamine in the presence of ascorbic acid at carbon nanotubes paste modified electrode
	Adela Ciobanu, Romania	Presenter
003	An association between physical activities and depression in working population
	Dalia Stropute, Lithuania	Presenter
004	The increase in Serotonin Transporter occupancy from single to multiple dosing is associated with treatment outcome in major depressive disorder
	Elena Akimova, Austria	Presenter
007	Modafinil reduces microsleep during partial sleep deprivation and improves antidepressant treatment response
	Johannes Beck, Switzerland	Presenter
008	No predictors of antidepressant response to Milnacipran was obtained using the Three Factor Structures of the Montgomery and Åsberg Depression Rating Scale in Japanese patients with major depressive disorders
	Hisashi Higuchi, Japan	Presenter
009	Predictors of antidepressant response to Fluvoxamine Obtained using the Three-Factor Structures of the Montgomery and Åsberg Depression Rating Scale for major depressive disorders in Japanese patients
	Hisashi Higuchi, Japan	Presenter
010	Neuropsychological impairment and high prevalence of depression in patients with chronic Hepatitis C virus
	Signe Groth Renvillard, Denmark	Presenter
011	Depression severity: Is it influenced by chronotypes?
	Enrique Gaspar, Mexico	Presenter
012	Administration of cannabinoid CB2 receptor antagonist AM630 decreased emotional-like behaviours after acute and chronic depressive stimuli
	Jorge Manzanares, Spain	Presenter
013	Overexpression of cannabinoid CB2 receptors results in decreased response to acute and chronic depressive stimuli
	Jorge Manzanares, Spain	Presenter
014	A specific memory profile in depression remitters following electroconvulsive therapy: Preliminary findings
	Maria Semkovska, Ireland	Presenter
015	Prevalence of perinatal depression in Portuguese women preliminary results
	Ana Telma Pereira, Portugal	Presenter
016	Efficacy and Safety of Desvenlafaxine 50 and 100 mg/d in the Treatment of Major Depressive Disorder: Results From 2 Placebo-Controlled Studies
	Karen Tourian, France	Presenter
017	Analysing depression using DASS-21 scale among diabetes in Malaysia
	Salmiah Mohd Ali, Malaysia	Presenter
018	Depression and rheumatoid arthritis - case report
	Nebojsa Ilic, Serbia and Montenegro	Presenter
019	The study of the relationship between depression and trust in god among undergraudate students
	Mohammad Mehdi Naderi, Iran	Presenter
020	Revealing of psychological problems at women
	Irina Bitchenko, Ukraine	Presenter

No.	S-15 - Symposium
Time:	14.00-15.30
Room:	Room 352AB
Topic:	Affective Disorders (Unipolar)
Track:	2 Clinical
Session title:	Brain-focussed treatments of depression
	Klaus Ebmeier, United Kingdom	Chair
	Thomas Schlaepfer, Germany	Co-Chair

001	New data on the mode of action of electroconvulsive therapy
	Allan Scott, United Kingdom	Speaker
002	New data on efficacy and safety of magnetic seizure therapy
	Mustafa Husain, USA	Speaker
003	New methodological developments in transcranial magnetic stimulation
	John Rothwell, United Kingdom	Speaker
004	New data on deep brain stimulation
	Thomas Schlaepfer, Germany	Speaker

No.	S-21 - Symposium
Time:	16.00-17.30
Room:	Salle Maillot
Topic:	Affective Disorders (Unipolar)
Track:	1 Basic
Session title:	Social cognition in depression and suicide: A neuroimaging perspective
	Jonathan Roiser, France	Chair
	Philippe Fossati, France	Co-Chair

001	Self perception in depressed patients and subjects with high risk for depression
	Philippe Fossati, France	Speaker
002	Neural circuits underlying anhedonia in major depressive disorder
	Jonathan Roiser, France	Speaker
003	Is suicide a specific disorder of social cognition?
	Fabrice Jollant, France	Speaker
004	Emotional and social memory
	Martin Lepage, Canada	Speaker

« previous day	Monday, 29. June 2009	next day »

No.	S-28 - Symposium
Time:	08.00-09.30
Room:	Room 352AB
Topic:	Affective Disorders (Unipolar)
Track:	1 Basic
Session title:	Neurobiology of sleep regulation and sleep deprivation and consequences for depression and somatic health
	Axel Steiger, Germany	Chair
	Edith Holsboer-Trachsler, Switzerland	Co-Chair

001	Sleep and neuroendocrine biomarkers as predictors for psychic health and depressive illness course in children and adults
	Martin Hatzinger, Switzerland	Speaker
002	Neuropeptidergic regulation of sleep and sleep deprivation
	Petra Schüssler, Germany	Speaker
003	Neurotransmitter regulation of sleep deprivation in depression
	Ulrich-Michael Hemmeter, Switzerland	Speaker
004	The consequences of chronically disrupted and restricted sleep: Insights from experimental studies in animals and relevance for depression
	Peter Meerlo, Netherlands	Speaker

No.	S-34 - Symposium
Time:	11.00-12.30
Room:	Room 252B
Topic:	Affective Disorders (Unipolar)
Track:	1 Basic
Session title:	Identifying biomarkers of depression: New insights from animal models
	Igor Branchi, Italy	Chair
	Mathias Schmidt, Germany	Co-Chair

001	Early environment shapes vulnerability to psychopathology in animal models of depression: Is altered metabolism a reliable biomarker?
	Igor Branchi, Italy	Speaker
002	Markers of neuronal network plasticity in mood disorders and antidepressant response
	Eero Castren, Finland	Speaker
003	Novel strategies to discover susceptibility and resilience biomarkers for stress-induced diseases
	Mathias Schmidt, Germany	Speaker
004	From inflammation to depression: A role for indoleamine 2,3 dioxygenase
	Robert Dantzer, USA	Speaker

No.	P-14 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Affective Disorders (Unipolar)
Session title:	Affective Disorders (Unipolar) II
	Goeran Hajak, Germany	Chair

001	Depression and body mass index in primary care patients: Impact of gender
	Adomas Bunevicius, Lithuania	Presenter
002	Association between major depressive disorder and anxiety disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA)
	Carmilla Licht, Netherlands	Presenter
003	Evidence for sustained improvement in memory deficits following computer assisted cognitive remediation in patients with mood disorders
	Liesel-Anne Meusel, Canada	Presenter
004	Is „male-type” depression specific for females, too?
	Zoltan Rihmer, Hungary	Presenter
005	Psychopathological and neuropsychological profiles of primary major depression and post - traumatic brain injury major depression
	Massimo Carlo Mauri, Italy	Presenter
006	Clinical caracteristics of female depression patients in East - South Serbia
	Aleksandra Petrovic, Serbia and Montenegro	Presenter
007	New options in monitoring the course of depressive disorders: Development and validation of a short screening for depression (DESC) using Rasch analysis
	Christine Norra, Germany	Presenter
008	Experimental challenge studies of central monoamine systems in humans: Comparison of methodology and neurophysiological effects
	Christine Norra, Germany	Presenter
009	Adrenal and thyroid axis activity and FT4 / FT3 ratio in depression
	Marie-Claude Mokrani, France	Presenter
010	Chronobiological HPA axis dysfunction in depression
	Marie-Claude Mokrani, France	Presenter
011	Dopamine function and cortisol secretion in depression
	Fabrice Duval, France	Presenter
012	Investigating the impact of spiritual therapy in treatment of depression (with emphasis on the Islamic Tradition)
	Ali Naghi Faghihi, Iran	Presenter
013	Depression and Omega-3 fatty acids in the general population of Greece: A preliminary study
	Greta Wozniak, Greece	Presenter
014	Efficacy and tolerability of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder (MDD)
	Heikki Katila, Finland	Presenter
015	Fluvoxamine induces the phosphorylation of Akt - 1 in PC12 cells
	Miho Nakano, Japan	Presenter
016	Attentional impairments in depression: Impact of depression sub-type and severity
	Andrew Kemp, Australia	Presenter
017	Depressive comorbidity in patients candidates to epileptic surgery
	Luis Pestana, Portugal	Presenter
018	QEEG prediction of response to rTMS and/or venlafaxine in patients with depressive disorder. A double-blind, single-centre, randomized study
	Martin Brunovsky, Czech Republic	Presenter
019	Brain-derived neurotrophic factor plasma level is reduced in antidepressant-free patients with late-onset depression
	Breno Diniz, Brazil	Presenter
020	Recovery from trauma-related major depression and bipolar disorder
	Ion Draghinda, Switzerland	Presenter
021	Deviant stress responses in girls at risk for familial depression. The TRAILS Study
	Esther Bouma, Netherlands	Presenter

No.	TG-04 - WFSBP Treatment Guidelines
Time:	16.00-17.30
Room:	Room 242A
Topic:	Affective Disorders (Unipolar)
Session title:	Unipolar depression
	Peter Whybrow, USA	Chair

	Michael Bauer, Germany	Presenter
	Gerardo M. Heinze, Mexico	Presenter

« previous day	Tuesday, 30. June 2009	next day »

No.	FC-15 - Free Communications
Time:	08.00-09.30
Room:	Room 351
Topic:	Affective Disorders (Unipolar)
Session title:	Affective Disorders (Unipolar) II
	Ulrich-Michael Hemmeter, Switzerland	Chair
	Edith Holsboer-Trachsler, Switzerland	Co-Chair

001	Inter-individual differences in positive affect and vulnerability to chronic stress in the rat: A model for male depression?
	Jaanus Harro, Estonia	Speaker
002	Depression is associated with decreased blood pressure but antidepressant use increases the risk for hypertension
	Carmilla Licht, Netherlands	Speaker
003	Association between lifetime hormonal factors and hormone therapy, with late-life depression in women
	Marie Laure Ancelin, France	Speaker
004	Anti-stress and anti-oxidative effects of St. John´s wort extract (STW 3-VI) in a model of chronic stress
	Olaf Kelber, Germany	Speaker
005	Depersonalization and depressive phenomenology in unipolar depression
	Olivera Zikic, Serbia and Montenegro	Speaker
006	HPA-axis activity in a large cohort of depressed and anxious subjects
	Sophie Vreeburg, Netherlands	Speaker

No.	S-57 - Symposium
Time:	16.00-17.30
Room:	Room 252B
Topic:	Affective Disorders (Unipolar)
Track:	2 Clinical
Session title:	Depression, vitamin D and light
	Witte Hoogendijk, Netherlands	Chair
	Consuelo Hopkins Wilkins, USA	Co-Chair

001	Vitamin D, light and parathyroid hormone in depression
	Witte Hoogendijk, Netherlands	Speaker
002	Positive effect of bright light in non-seasonal depression
	Ritsaert Lieverse, Netherlands	Speaker
003	Developmental vitamin D deficiency alters adult behaviour
	Thomas Burne, Australia	Speaker
004	Vitamin D deficiency is associated with low mood and worse cognitive performance
	Consuelo Hopkins Wilkins, USA	Speaker

« previous day	Wednesday, 1. July 2009	next day »

No.	FC-26 - Free Communications
Time:	12.30-14.00
Room:	Room 351
Topic:	Affective Disorders (Unipolar)
Session title:	Affective Disorders (Unipolar) III
	Philippe Fossati, France	Chair
	Alexandre Dailliet, Belgium	Co-Chair

001	Higher psychological pain during a major depressive episode may be a factor of vulnerability to suicidal ideation and act
	Emilie Olié, France	Speaker
002	Association between IL-12 secretion levels in major depressive disorder and symptoms severity, before and after mitogen stimulation
	Platon Christopoulos, Greece	Speaker
003	Localization of white matter lesions and effect of vascular risk factors in late-onset major depression
	Rikke Dalby, Denmark	Speaker
004	Cognitive effects of electroconvulsive therapy in depression: A meta-analysis
	Maria Semkovska, Ireland	Speaker
005	Early separations as risk factor for later depressive, panic, generalized anxious and paranoid disorder
	Dusan Lazarevic, Serbia and Montenegro	Speaker
006	Neurobiological bases of suicidality in major depression
	Martin Desseilles, Belgium	Speaker

No.	P-33 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Affective Disorders (Unipolar)
Session title:	Affective Disorders (Unipolar) III
	E. Mohandas, India	Chair

001	Preeclampsia in pregnant women depression
	Aida Ansari, Iran	Presenter
002	Depression post myocardial infarction: A cross sectional study in University Malaya Medical Center
	Amer Siddiq Amer Nordin, Malaysia	Presenter
003	Associations between cyclothymic temperament and bipolarity factors in recurrent depressive patients
	Anwar Mechri, Tunisia	Presenter
004	Cognitive inhibition and working memory in unipolar depression
	Benedicte Gohier, France	Presenter
006	Disfunctional cognitive schemes in depressed patients
	Iosif Gabos Grecu, Romania	Presenter
007	Outcome prediction of the Hamilton depression rating scale (HAM-D 17 item) in patients with moderate depression - an artificial neural network (ANN) approach combined with wavelet decomposition
	Jürgen Müller, Germany	Presenter
008	High - dose St. John´s wort extract STW 3 - VI is a safe and effective treatment option in mild depression - results of a revaluation
	Jürgen Müller, Germany	Presenter
009	Investigating models of affect: Comparison of regional brain asymmetry in MDD and PTSD
	Kristi Griffiths, Australia	Presenter
010	VEGF serum levels in depressed patients during SSRI antidepressant treatment
	Luisella Bocchio-Chiavetto, Italy	Presenter
011	Cardiovascular disorders in comorbidity with depression
	Marija Burgic-Radmanovic, Bosnia and Herzegovina	Presenter
012	Extended release quetiapine fumarate (quetiapine XR) monotherapy for the treatment of patients with major depressive disorder (MDD): A randomised, placebo-controlled clinical trial
	Nizar El-Khalili, USA	Presenter
013	Late-life depression: Differences between early and late onset illness in a melancholic hospitalized sample
	Pilar Alvarez, Spain	Presenter
014	Platelet serotonergic binding sites in melancholic depression with and without psychotic features: Relationship with clinical and follow-up variables
	Pilar Alvarez, Spain	Presenter
015	Circular depressions and factor of seasonality
	Sergejus Andruskevicius, Lithuania	Presenter
016	Brain lipid peroxidation enzymes, stress and stress - induced anhedonia in CD1 mice
	Tatyana Strekalova, Netherlands	Presenter
017	Associations between depression and cardiovascular disease in patients with late onset single episode major depressive disorder
	Torben Albert Devantier, Denmark	Presenter
018	Subclinical hypothyroidism predicts treatment outcome of inpatients with major depressive disorder
	Toshimi Owashi, Japan	Presenter
019	Homeopathy versus fluoxetine for moderate to severe depression: Double-blind, randomized non-inferiority trial
	Ubiratan Adler, Brazil	Presenter
020	Amygdala volumes in a sample of current depressed and remitted depressed patients and healthy controls
	Valentina Lorenzetti, Australia	Presenter

No.	S-74 - Symposium
Time:	16.00-17.30
Room:	Room 241
Topic:	Affective Disorders (Unipolar)
Track:	2 Clinical
Session title:	Chronobiological treatment combinations for major affective disorder: Clinical outcome and neurobiological correlates
	Anna Wirz-Justice, Switzerland	Chair
	Sylvie Royant-Parola, France	Co-Chair

001	Chronobiology as a paradigm for biological psychiatry
	Anna Wirz-Justice, Switzerland	Speaker
002	Nuts and bolts of chronotherapeutic interventions
	Michael Terman, USA	Speaker
003	Wake and light therapy in non-seasonal major depression
	Klaus Martiny, Denmark	Speaker
004	Wake and light therapy in bipolar illness: fMRI correlates of response
	Francesco Benedetti, Italy	Speaker

« previous day	Thursday, 2. July 2009

No.	S-78 - Symposium
Time:	08.00-09.30
Room:	Room 352AB
Topic:	Affective Disorders (Unipolar)
Track:	2 Clinical
Session title:	The emerging role of TMS in the treatment of psychiatric disorders
	Philip Janicak, USA	Chair
	Abraham Zangen, Israel	Co-Chair

001	Transcranial magnetic stimulation of deep brain regions: An overview and ongoing studies in psychiatric patients and healthy subjects
	Abraham Zangen, Israel	Speaker
002	Predictive factors and biomarkers for TMS in depression
	Jeffrey Rado, USA	Speaker
003	TMS for other neuropsychiatric disorders
	Eman Khedr, Egypt	Speaker
004	Efficacy of TMS for depression and review of large sham-controlled trial
	Philip Janicak, USA	Speaker

No.	SL-04 - Special Lecture
Time:	11.00-12.00
Room:	Blue Amphitheatre
Topic:	Affective Disorders (Unipolar)
Session title:	Depression and Mens Health - what s new? under the auspices of WFSBP and ISMH
	N N	Chair

001	Depression and Mens Health - what s new?
	Siegfried Meryn, Austria	Speaker

No.	W-12 - Workshop
Time:	11.00-12.30
Room:	Room 242B
Topic:	Affective Disorders (Unipolar)
Session title:	Is there still a place for unipolar depression?
	Andrea Lopez Mato, Argentina	Chair

001	Genetic differences between unipolar and bipolar depression
	Alejo Corrales, Argentina	Speaker
002	Clinical differences between unipolar and bipolar depression
	Jose Luis Ayuso Gutierrez, Spain	Speaker
003	Psychoneuroimmunoendocrinological differences between unipolar and bipolar depression
	Andrea Lopez Mato, Argentina	Speaker
004	Therapeutical differences between unipolar and bipolar depression
	Raquel Teresa Zamora-Cabral, Uruguay	Speaker

No.	P-43 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Affective Disorders (Unipolar)
Session title:	Affective Disorders (Unipolar) IV
	Michael Bauer, Germany	Chair

001	Epidemiology of female obesity and depression in different age groups
	Alina Matynova, Russia	Presenter
002	Neurotic hostility explains the association between depressive mood and mortality: Evidence from the French GAZEL cohort study
	Cedric Lemogne, France	Presenter
004	Patients suffering from major depressive disorder show an altered interaction between cardiac vagal influence and delta sleep EEG
	Fabrice Jurysta, Belgium	Presenter
005	Seasonal distribution of mania in a psychiatric emergency room
	Fernando Volpe, Brazil	Presenter
006	Premorbid sleep, cognitive and activity circadian profile in depressed patients
	Giuseppe Bersani, Italy	Presenter
007	Prevalence of sleep disorders among patients with anxiety and depressive symptoms
	Jozef Dragasek, Slovak Republic	Presenter
008	Primary and Secondary Interferon-Alpha induced depression: Cytokine levels and depression ratings
	Kimberley Smith, Ireland	Presenter
009	Comorbidity between major depression and arthritis
	Lilijana Oruc, Bosnia and Herzegovina	Presenter
010	Decreased aldosterone and renin in suicide attempters with major depressive disorder
	Ludvig Hallberg, Sweden	Presenter
011	Health - related quality of life in depression patients
	Margarita Staniute, Lithuania	Presenter
012	The effect of saffron extract on behavioral changes and depression in male rates
	Mostafa Hamdieh, Iran	Presenter
013	Increased plasma levels of novel monoamine oxidase, renalase, in patients with major depressive disorder and panic disorder
	Nina Eikelis, Australia	Presenter
014	Tryptophan and Kynurenine metabolism abnormalities in an experimental model of major depressive disorder: The unpredictable chronic mild stress in mice
	Pascal Barone, France	Presenter
015	Depression, relationship and communication
	Paula Santos, Portugal	Presenter
016	Assessment of the respective role of clinical factors - institutionalisation, disease severity and disease duration - on the observed hypovitaminosis D in patients with major depression
	Raoul Belzeaux, France	Presenter
018	Neurobiology of depression: New perspectives for an old disease
	Rui Malta, Portugal	Presenter
019	A Study of Anger, Alexithymia, and Depression in Korean Patients with Functional Dyspepsia
	Sang-Yeol Lee, Korea, Republic of	Presenter
020	Effect of Tramadol on corticosteroid receptor function in patients with major depression
	Irene Minenko, Ukraine	Presenter

« Back

---